Your browser doesn't support javascript.
loading
Bufalin suppresses hepatocarcinogenesis by targeting ß-catenin/TCF signaling via cell cycle-related kinase.
Yu, Zhuo; Feng, Hai; Sun, Xuehua; Zhuo, Yunhui; Li, Man; Zhou, Zhenhua; Huang, Lingying; Jiang, Yun; Zhu, Xiaojun; Zhang, Xin; Le, Fan; Zheng, Chao; Cheng, Alfred Szelok; Gao, Yueqiu.
Afiliação
  • Yu Z; Liver Disease Department, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China.
  • Feng H; Department of pharmacology, School of Pharmacy, Harbin Medical University, Harbin, P.R. China.
  • Sun X; Liver Disease Department, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China.
  • Zhuo Y; Liver Disease Department, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China.
  • Li M; Laboratory of Cellular Immunity, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China.
  • Zhou Z; Laboratory of Cellular Immunity, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China.
  • Huang L; Liver Disease Department, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China.
  • Jiang Y; Liver Disease Department, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China.
  • Zhu X; Liver Disease Department, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China.
  • Zhang X; Laboratory of Cellular Immunity, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China.
  • Le F; Liver Disease Department, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China.
  • Zheng C; Liver Disease Department, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China.
  • Cheng AS; School of Biomedical Sciences, State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, SAR, P.R. China.
  • Gao Y; Liver Disease Department, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China. gaoyueqiu@hotmail.com.
Sci Rep ; 8(1): 3891, 2018 03 01.
Article em En | MEDLINE | ID: mdl-29497076

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bufanolídeos / Carcinoma Hepatocelular / Quinases Ciclina-Dependentes Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2018 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bufanolídeos / Carcinoma Hepatocelular / Quinases Ciclina-Dependentes Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2018 Tipo de documento: Article País de publicação: Reino Unido